ML23338A331
| ML23338A331 | |
| Person / Time | |
|---|---|
| Site: | 03036654 |
| Issue date: | 12/04/2023 |
| From: | Casey Alldredge NRC/RGN-IV/DRSS/MLB |
| To: | Document Control Desk |
| References | |
| License-637399-205288 | |
| Download: ML23338A331 (1) | |
See also: IR 05000277/1984001
Text
NRC FORM 374 PAGE OF1 3PAGES
U.S. NUCLEAR REGULATORY COMMISSION Amendment No. 9
MATERIALS LICENSE
Pursuant to the Atomic Energy Act of 1954 , as amended, the Energy Reorganization Act of 1974 (Public Law 93-438) , and Title 10 , Code of Federal Regulations, Chapter I ,
Parts 30 , 31 , 32 , 33 , 34 , 35 , 36 , 37 , 39 , 40 , 70 and 71 , and in reliance on statements and representations heretofore made by the licensee, a license is hereby issued
authorizing the licensee to receive, acquire , possess , and transfer byproduct, source , and special nuclear material designated below; to use such material for the purpose (s)
and at the place (s) designated below; to deliver or transfer such material to persons authorized to receive it in accordance with the regulations of the applicable Part (s). This
license shall be deemed to contain the conditions specified in Section 183 of the Atomic Energy Act of 1954 , as amended, and is subject to all applicable rules, regulations , and
orders of the Nuclear Regulatory Commission now or hereafter in effect and to any conditions specified below .
Licensee In accordance with letter dated 4. Expiration Date: December 31, 2024
1. Alaska Native Medical Center September 26, 2023,
5. Docket No.: 030-36654
2. 4315 Diplomacy Drive 3. License No.: 50-27784-01 is Reference No.:
Anchorage, AK 99508 amended in its entirety to read as
follows:
6. 7. 8.Byproduct, source, Chemical and/or physical form Maximum amount that licensee 9. Authorized use
and/or special nuclear may possess at any one time
material under this license
A. For use in imaging and localization Any byproduct material A.Any As NeededA.A.
permitted by 10 CFR studies permitted by 10 CFR 35.200.
35.200
NRC FORM 374A U.S. NUCLEAR REGULATORY COMMISSION PAGE 32OFPAGES
License No.: Docket or Reference No.:50-27784-01
MATERIALS LICENSE 030-36654
SUPPLEMENTARY SHEET Amendment No. 9
CONDITIONS
10. Licensed material may be used or stored at the licensee's facilities located at 4315 Diplomacy Drive, Anchorage, Alaska, 99508.
11. The Radiation Safety Officer (RSO) for this license is Kenneth Harper, M.S.
12. Licensed material shall only be used by, or under the supervision of:
A. Individuals permitted to work as authorized users, authorized nuclear pharmacists, and/or authorized medical physicists in accordance
with 10 CFR 35.13 and 10 CFR 35.14.
B. The following individuals are authorized users for the material and medical uses as indicated:
Authorized Users Material and Use
Leslie R. Bryant III, M.D. 35.200
Lee Holder, D.O. 35.200
Howard L. Katz, M.D. 35.200
Tracy C. Marchant, D.O. 35.200
Jaren T. Meldrum, M.D. 35.200
John Midthun, M.D. 35.200
Joel K. Verbrugge, M.D. 35.200
13. In addition to the possession limits in Item 8, the licensee shall further restrict the possession of licensed material to quantities below the
minimum limit specified in 10 CFR 30.35(d) for establishing financial assurance for decommissioning.
NRC FORM 374A U.S. NUCLEAR REGULATORY COMMISSION PAGE 33OFPAGES
License No.: Docket or Reference No.:50-27784-01
MATERIALS LICENSE 030-36654
SUPPLEMENTARY SHEET Amendment No. 9
14. Except as specifically provided otherwise in this license, the licensee shall conduct its program in accordance with the statements,
representations, and procedures contained in the documents, including any enclosures, listed below. This license condition applies only to
those procedures that are required to be submitted in accordance with the regulations. Additionally, this license condition does not limit the
licensee's ability to make changes to the radiation protection program as provided for in 10 CFR 35.26. The U.S. Nuclear Regulatory
Commission's regulations shall govern unless the statements, representations, and procedures in the licensee's application and
correspondence are more restrictive than the regulations.
A. Application dated September 17, 2014 (ML14287A628)
B. Letter dated December 8, 2014 (ML14346A310)
C. Letter dated May 10, 2018 (ML18155A514)
D. Email dated November 30, 2023 (ML23335A169)
FOR THE U .S. NUCLEAR REGULATORY COMMISSION
Date: December 4, 2023 By:
Region 4